Irisin Recovers Osteoarthritic Chondrocytes In Vitro

Area of Science:

• Biochemistry
• Cell Biology
• Orthopedics

Background:

• Physical exercise benefits osteoarthritis by promoting weight loss and improving joint function.
• Irisin, a myokine released during muscle contraction, exhibits anabolic effects on various cell types.
• The role of irisin in human osteoarthritic chondrocytes (hOAC) requires further investigation.

Purpose of the Study:

• To investigate the in vitro effects of irisin on human osteoarthritic chondrocytes (hOAC).
• To determine if irisin enhances hOAC metabolism and proliferation.
• To elucidate the signaling pathways involved in irisin's action on hOAC.

Main Methods:

• hOAC were cultured and treated with either phosphate-buffered saline (control) or human recombinant irisin.
• Assessed cell proliferation, glycosaminoglycan content, and type II/X collagen gene/protein expression.
• Evaluated the involvement of p38/ERK, Akt, JNK, and NFκB signaling pathways.
• Quantified gene expression of inflammatory cytokines (IL-1, IL-6), matrix metalloproteinases (MMP-1, MMP-13), iNOS, and their inhibitors (TIMP-1, TIMP-3).

Main Results:

• Irisin significantly increased hOAC proliferation and type II collagen expression while decreasing type X collagen.
• Irisin reduced the expression of IL-1, IL-6, MMP-1, MMP-13, and iNOS.
• Irisin treatment led to increased levels of TIMP-1 and TIMP-3.
• Observed inhibition of p38, Akt, JNK, and NFκB signaling pathways by irisin.

Conclusions:

• Irisin stimulates proliferation and anabolism in hOAC.
• Irisin inhibits catabolism in hOAC by reducing inflammatory and degradative markers.
• The effects of irisin are mediated through the inactivation of p38, Akt, JNK, and NFκB pathways.
• Suggests a cross-talk mechanism between muscle-derived irisin and cartilage health in osteoarthritis.